Your search history is turned on.
Date: March 28, 2024 Jurisdictions: Alberta, British Columbia
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC File Number 001-40409 CUSIP Number 39878L 308 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): Form 10-K Form 20-F Form 11-K Form 10-Q Form 10-D Form N-SAR Form N-CSR For Period Ended: December 31, 2023 ...
Date: February 22, 2024 Jurisdictions: Alberta, British Columbia
CannaPharmaRX revised Material Change Report.pdf CannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement with Cantek CALGARY, AB / ACCESSWIRE / February 15, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has entered into a strategic Supply Agreemen...
CannaPharmaRX revised Material Change Report.pdf 1. SUPPLY AGREEMENT This Supply Agreement, dated as of February 12th, 2024 (the Agreement), is entered into by and between CannaPharmaRX, Inc., a Delaware corporation (Supplier), and D.N.S. CANTEK 2019 LTD, an Israeli limited corporation, or its Affiliates and assigns (Buyer, and together with Supplier, th...
CannaPharmaRX revised Material Change Report.pdf UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2024 CannaPharmaRX...
Date: February 19, 2024 Jurisdictions: Alberta, British Columbia
CannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement with Cantek CALGARY, AB / ACCESSWIRE / February 15, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has entered into a strategic Supply Agreement (the "Agreement") with Cantek Holdings ("Cantek"), one of Israe...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2024 CannaPharmaRX, Inc. (Exact name of registrant as specified in its charter) Delaware ...
Date: December 6, 2023 Jurisdictions: Alberta, British Columbia
Execution Version AMENDED AND RESTATED MEMBERSHIP INTERESTS PURCHASE AGREEMENT between KOZE INVESTMENTS, LLC and AMIR TAL (Sellers) ELLIOT ZEMEL As Sellers Representative and CANNAPHARMARX, INC. (Buyer) AMENDED AND RESTATED MEMBERSHIP INTERESTS PURCHASE AGREEMENT This Amended and Restated Membership Interests Purchase Agreem...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 22, 2023 CannaPharmaRX, Inc. (Exact name of registrant as specified in its charter) Delaware 333-251016 27-4635140 (State or other jurisdict...
Date: November 21, 2023 Jurisdictions: Alberta, British Columbia
CERTIFICATION PURSUANT TO 18 USC, SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES OXLEY ACT OF 2002 I, Oliver Foeste, certify that: 1. I have reviewed this quarterly report on Form 10-Q of CannaPharmaRx, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary in ord...